These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19641099)

  • 1. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys.
    Lieberman MM; Nerurkar VR; Luo H; Cropp B; Carrion R; de la Garza M; Coller BA; Clements D; Ogata S; Wong T; Martyak T; Weeks-Levy C
    Clin Vaccine Immunol; 2009 Sep; 16(9):1332-7. PubMed ID: 19641099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.
    Lieberman MM; Clements DE; Ogata S; Wang G; Corpuz G; Wong T; Martyak T; Gilson L; Coller BA; Leung J; Watts DM; Tesh RB; Siirin M; Travassos da Rosa A; Humphreys T; Weeks-Levy C
    Vaccine; 2007 Jan; 25(3):414-23. PubMed ID: 16996661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates.
    Govindarajan D; Meschino S; Guan L; Clements DE; ter Meulen JH; Casimiro DR; Coller BA; Bett AJ
    Vaccine; 2015 Aug; 33(33):4105-16. PubMed ID: 26144900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of captive nēnē (Branta sandvicensis) against West Nile virus using a protein-based vaccine (WN-80E).
    Jarvi SI; Hu D; Misajon K; Coller BA; Wong T; Lieberman MM
    J Wildl Dis; 2013 Jan; 49(1):152-6. PubMed ID: 23307381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
    Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
    Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.
    Clements DE; Coller BA; Lieberman MM; Ogata S; Wang G; Harada KE; Putnak JR; Ivy JM; McDonell M; Bignami GS; Peters ID; Leung J; Weeks-Levy C; Nakano ET; Humphreys T
    Vaccine; 2010 Mar; 28(15):2705-15. PubMed ID: 20097152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK; Takasaki T; Kotaki A; Kurane I
    Virology; 2008 Apr; 374(1):60-70. PubMed ID: 18221765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters.
    Siirin MT; Travassos da Rosa AP; Newman P; Weeks-Levy C; Coller BA; Xiao SY; Lieberman MM; Watts DM
    Am J Trop Med Hyg; 2008 Dec; 79(6):955-62. PubMed ID: 19052311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
    PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
    Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
    Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.
    Maximova OA; Speicher JM; Skinner JR; Murphy BR; St Claire MC; Ragland DR; Herbert RL; Pare DR; Moore RM; Pletnev AG
    Vaccine; 2014 May; 32(26):3187-97. PubMed ID: 24736001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
    Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
    Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.
    Watts DM; Tesh RB; Siirin M; Rosa AT; Newman PC; Clements DE; Ogata S; Coller BA; Weeks-Levy C; Lieberman MM
    Vaccine; 2007 Apr; 25(15):2913-8. PubMed ID: 17067727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
    Verstrepen BE; Oostermeijer H; Fagrouch Z; van Heteren M; Niphuis H; Haaksma T; Kondova I; Bogers WM; de Filette M; Sanders N; Stertman L; Magnusson S; Lőrincz O; Lisziewicz J; Barzon L; Palù G; Diamond MS; Chabierski S; Ulbert S; Verschoor EJ
    PLoS One; 2014; 9(11):e112568. PubMed ID: 25392925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.